dacarbazine
Showing 1 - 25 of 113
Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)
Not yet recruiting
- Hodgkin Lymphoma
- Brentuximab vedotin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 20, 2023
LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)
Suspended
- LMS - Leiomyosarcoma
- Uterine Leiomyosarcoma
- Gemcitabine
- +5 more
-
Stanford, CaliforniaStanford University
Oct 24, 2022
Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)
Recruiting
- Classical Hodgkin Lymphoma
- Dacarbazine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)
Recruiting
- Metastatic Uveal Melanoma
- IDE196
- +5 more
-
Grand Rapids, MichiganThe Cancer and Hematology Centers
Aug 14, 2023
Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)
Completed
- Hodgkin Disease
- Brentuximab vedotin
- +3 more
-
Aurora, Colorado
- +13 more
Jun 17, 2022
Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)
Active, not recruiting
- Classical Hodgkin Lymphoma
- Nivolumab
- +3 more
-
Cologne, GermanyUniversity Hospital of Cologne
Aug 5, 2022
Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)
Recruiting
- Classical Hodgkin Lymphoma
- Pembrolizumab
- +4 more
-
Charlottesville, VirginiaUniversity of Virginia
Jul 27, 2022
Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)
Completed
- Malignant Melanoma
- Recurrent Melanoma
- Dacarbazine
- +2 more
- (no location specified)
Oct 18, 2020
HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,
Active, not recruiting
- HIV Infection
- +3 more
- brentuximab vedotin
- +3 more
-
Clamart, France
- +5 more
Aug 11, 2022
Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)
Recruiting
- Hodgkin Lymphoma
- Involved site radiotherapy
- +6 more
-
Aberdeen, United Kingdom
- +6 more
May 24, 2022
Melanoma Trial in Germany (PTK787/ZK 222584, Dacarbazine)
Terminated
- Melanoma
- PTK787/ZK 222584
- Dacarbazine
-
Essen, Germany
- +3 more
Sep 28, 2021
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022
Soft Tissue Sarcoma Trial in Münster (Dacarbazine, onfekafusp alfa)
Recruiting
- Soft Tissue Sarcoma
- Dacarbazine
- onfekafusp alfa
-
Bordeaux, France
- +15 more
Dec 22, 2022
Classical Hodgkin Lymphoma Trial in Zhengzhou (Camrelizumab, Epirubicin, Vincristine)
Recruiting
- Classical Hodgkin Lymphoma
- Camrelizumab
- +3 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 29, 2020
HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)
Completed
- HIV Infections
- Hodgkin's Disease
- Vinblastine sulfate
- +4 more
-
Birmingham, Alabama
- +7 more
Oct 26, 2021
AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United
Active, not recruiting
- AIDS-Related Hodgkin Lymphoma
- +11 more
- Brentuximab Vedotin
- +4 more
-
La Jolla, California
- +27 more
Jul 27, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab
Recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
- +7 more
-
Bologna, Italy
- +12 more
Nov 10, 2021
Hodgkin Lymphoma, Adult Trial in Moscow (Doxorubicin, Bleomycin, Vinblastine)
Recruiting
- Hodgkin Lymphoma, Adult
- Doxorubicin
- +7 more
-
Moscow, Russian FederationThe Federal Budget-Funded Institution National Medical Surgical
Nov 20, 2020
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)
Completed
- Stage IV Melanoma
- recombinant interferon alfa-2b
- +4 more
-
Cleveland, OhioCleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Jul 22, 2020